Marvel Custom Solutions has partnered with Seb Tucknott, the founder of the online platform IBDRelief and pharmaceutical company Takeda, to create a new ... Read more
Researchers at Georgia State University’s Institute for Biomedical Sciences won a $1.4 million federal grant to study novel therapeutic approaches to treat inflammatory bowel ... Read more
Low levels of the enzyme PTPN2 promote the development a group of T-cells with pro-inflammatory properties, contributing to syndromes such as Crohn’s disease, scientists ... Read more
Editor’s note: In the second part of the series “Crohn’s Disease Questions,” Mary Horsley discusses comments about IBD that can hurt. Read ... Read more
Directors from pharmaceutical and health insurance companies and gastroenterologists in the United States have expressed a positive opinion overall about the use ... Read more